Fasting plasma glucose 6–12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis

AIMS: To evaluate whether fasting plasma glucose values measured early during insulin therapy can identify patients with Type 2 diabetes who may not achieve adequate glycaemic control after 6 months and will require additional treatment. METHODS: Patient-level data from seven prospective, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Karl, D, Zhou, R, Vlajnic, A, Riddle, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504344/
https://www.ncbi.nlm.nih.gov/pubmed/22413808
http://dx.doi.org/10.1111/j.1464-5491.2012.03640.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504344/
https://www.ncbi.nlm.nih.gov/pubmed/22413808
http://dx.doi.org/10.1111/j.1464-5491.2012.03640.x

Ejemplares similares